Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex

Cited 79 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorY I Chung-
dc.contributor.authorS K Kim-
dc.contributor.authorY K Lee-
dc.contributor.authorSu-Jin Park-
dc.contributor.authorK O Cho-
dc.contributor.authorS H Yuk-
dc.contributor.authorG Tae-
dc.contributor.authorY H Kim-
dc.date.accessioned2017-04-19T09:18:25Z-
dc.date.available2017-04-19T09:18:25Z-
dc.date.issued2010-
dc.identifier.issn0168-3659-
dc.identifier.uri10.1016/j.jconrel.2010.01.010ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/9503-
dc.description.abstractWe investigated the angiogenic bioactivity and therapeutic angiogenic effect of vascular endothelial growth factor (VEGF) administration by the heparin-functionalized nanoparticle-fibrin gel complex. The markedly increased bioactivity was observed by the VEGF-loaded nanoparticle-fibrin gel complex, compared to the VEGF-loaded fibrin gel, the nanoparticle-fibrin gel complex without VEGF, or fibrin gel (control) in terms of the capillary density in a mouse subcutaneous implantation model. Furthermore, the VEGF-loaded nanoparticle-fibrin gel complex significantly enhanced the therapeutic angiogenic effect in a rabbit ischemic hind limb model: the noticeable increase in the recovered calf blood pressure, the angiographic score, and the density of collaterals, as well as the stable maintenance of the organized collaterals, compared to the VEGF-loaded fibrin gel. These results show the enhanced angiogenic potential of VEGF administration by the proposed heparin-functionalized nanoparticle-fibrin gel complex.-
dc.publisherElsevier-
dc.titleEfficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex-
dc.title.alternativeEfficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex-
dc.typeArticle-
dc.citation.titleJournal of Controlled Release-
dc.citation.number3-
dc.citation.endPage289-
dc.citation.startPage282-
dc.citation.volume143-
dc.contributor.affiliatedAuthorSu-Jin Park-
dc.contributor.alternativeName정용일-
dc.contributor.alternativeName김상기-
dc.contributor.alternativeName이윤경-
dc.contributor.alternativeName박수진-
dc.contributor.alternativeName조경오-
dc.contributor.alternativeName육순홍-
dc.contributor.alternativeName태기융-
dc.contributor.alternativeName김영하-
dc.identifier.bibliographicCitationJournal of Controlled Release, vol. 143, no. 3, pp. 282-289-
dc.identifier.doi10.1016/j.jconrel.2010.01.010-
dc.subject.keywordAngiogenesis-
dc.subject.keywordControlled release-
dc.subject.keywordFibrin-
dc.subject.keywordGrowth factors-
dc.subject.keywordHeparin-
dc.subject.localAngiogenesis-
dc.subject.localangiogenesis-
dc.subject.localcontrolled release-
dc.subject.localControlled release-
dc.subject.localFibrin-
dc.subject.localfibrin-
dc.subject.localgrowth factor-
dc.subject.localGrowth Factor-
dc.subject.localGrowth factors-
dc.subject.localGrowth factor-
dc.subject.localHeparin-
dc.description.journalClassY-
Appears in Collections:
Jeonbuk Branch Institute > Functional Biomaterial Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.